The Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI) welcomes you to attend its annual meeting being held on Friday 18th November at the Wellcome Collection Conference Centre, London from 13h30 to 17h30.The Association has been in existence for over nearly 2 decades and has forged links with both other scientific societies with similar interests and with professional bodies such as the ABPI and ICR. The AHPPI's mission is to offer a framework for discussion and to exchange on current topics in applied Human Pharmacology and early phase drug development. Its aim is also to provide training, education and guidance and provide a forum for innovation and the development of new methods and efficiencies.The topic of this meeting will focus on "Accelerating Early Phase Clinical Development in the UK", and as always we expect to have a panel of excellent speakers from such organisations as ABPI, MHRA, NHS, pharmaceutical and CRO industries. For further details for what's in store for the day, please click here to view the full meeting agenda or here to register.Furthermore there will be the opportunity to attend the guided tours of the Wellcome collections and exhibitions. If you are interested in attending a tour on the day of the AHPPI meeting, please contact us for more details.This meeting has been awarded four Continuing Professional Development points by the Faculty of Pharmaceutical Medicine and is open to AHPPI members and non-members. On behalf of the AHPPI we cordially invite you to attend and look forward to seeing you next month!

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event